![](/img/cover-not-exists.png)
High-Dose Recombinant Interleukin-2 Alone: A Regimen With Limited Activity in the Treatment of Advanced Renal Cell Carcinoma
Abrams, J. S., Rayner, A. A., Wiernik, P. H., Parkinson, D. R., Eisenberger, M., Aronson, F. R., Gucalp, R., Atkins, M. B., Hawkins, M. J.Volume:
82
Language:
english
Journal:
JNCI Journal of the National Cancer Institute
DOI:
10.1093/jnci/82.14.1202
Date:
July, 1990
File:
PDF, 560 KB
english, 1990